Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
09/18/2003 | WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
09/18/2003 | WO2003075924A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
09/18/2003 | WO2003075922A1 Nitrogen monoxide synthase inhibitors |
09/18/2003 | WO2003075858A2 Bicyclic heterocycles for the treatment of diabetes and other diseases |
09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
09/18/2003 | WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity |
09/18/2003 | WO2003075836A2 Cathepsin cysteine protease inhibitors |
09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
09/18/2003 | WO2003053368A3 Chalcone derivatives and their use to treat diseases |
09/18/2003 | US20030176710 1,3-dioxane compounds containing oxo group |
09/18/2003 | US20030176708 Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
09/18/2003 | US20030176701 Di-or triaza-spiro [4,5] decane derivatives |
09/18/2003 | US20030176695 Such as N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-methyl-isonicotinamide for treatment of disorders of the central nervous system; neuroprotectants |
09/18/2003 | US20030176485 Calcium receptor active compounds |
09/18/2003 | US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
09/18/2003 | US20030176474 Modulators of Rho C activity |
09/18/2003 | US20030176473 For use in cancer therapy |
09/18/2003 | US20030176465 Cyclic amino acid derivatives |
09/18/2003 | US20030176454 N-coating heterocyclic compounds |
09/18/2003 | US20030176447 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
09/18/2003 | US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs |
09/18/2003 | US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds |
09/18/2003 | US20030176412 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists |
09/18/2003 | US20030176318 Administering a therapeutically effective amount of a temporary p53 inhibitor to an individual suffering from the disease or condition |
09/18/2003 | CA2478921A1 Novel chalcone derivatives and uses thereof |
09/18/2003 | CA2478765A1 Bicyclic heterocycles for the treatment of diabetes and other diseases |
09/18/2003 | CA2478342A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
09/17/2003 | EP1344771A1 2-alkoxy-phenylsulphonic acid derivatives as intermediates for herbicidal sulphonylamino(thio)carbonyl compounds |
09/17/2003 | EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
09/17/2003 | EP1343775A2 Piperazine derivatives |
09/17/2003 | EP1343773A1 Thiazole derivatives for traeing ppar related disorders |
09/17/2003 | EP1343772A1 Thia- and oxazoles and their use as ppars activators |
09/17/2003 | EP1343561A1 Serine protease inhibitors |
09/17/2003 | EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
09/17/2003 | EP1230230B1 Indeno-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
09/17/2003 | EP1042327B1 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
09/17/2003 | EP0959906B1 Delta 1,6 bicyclo [4,4,0] functional dyes for contrast enhancement in optical imaging |
09/17/2003 | EP0906293B1 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides |
09/17/2003 | CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
09/17/2003 | CN1443169A Chemical process for extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
09/17/2003 | CN1443155A Compounds to treat alzheimer's disease |
09/17/2003 | CN1443068A Combinations of depepotidyl peptidase IV inhibitors and other antidiabetic agents for treatment of diabete mellitus |
09/17/2003 | CN1121401C Aminophenol derivates |
09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
09/16/2003 | US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) |
09/16/2003 | US6620830 Certain thiazolidinedione, oxadiazolidinedione, and triazolone compounds which are thyroid receptor ligands |
09/16/2003 | US6620828 Antiproliferative agents |
09/16/2003 | US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
09/16/2003 | US6620767 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
09/16/2003 | CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids |
09/16/2003 | CA2069165C Stabilization of aqueous hydroxylamine solutions |
09/16/2003 | CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures |
09/12/2003 | WO2003074521A1 Derivatives of epothilone b and d and synthesis thereof |
09/12/2003 | WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles |
09/12/2003 | WO2003074495A1 Hppars activators |
09/12/2003 | WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides |
09/12/2003 | WO2003074475A2 Substituted aryl ketones |
09/12/2003 | WO2003074052A1 Thiazole and oxazole derivatives that modulate ppar activity |
09/12/2003 | WO2003074051A1 Substituted thiazoles and oxazoles that modulate ppar activity |
09/12/2003 | WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity |
09/12/2003 | CA2478520A1 Thiazole and oxazole derivatives which modulate ppar activity |
09/12/2003 | CA2478164A1 Substituted thiazoles and oxazoles that modulate ppar activity |
09/12/2003 | CA2476580A1 Thiazole and oxazole derivatives that modulate ppar activity |
09/11/2003 | US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
09/11/2003 | US20030171591 Process for producing optically active sulfoxide derivative |
09/11/2003 | US20030171411 Amide derivatives as therapeutic agents |
09/11/2003 | US20030171399 Quinolinyl and benzothiazolyl modulators |
09/11/2003 | US20030171377 Therapy for non-insulin dependent diabetes |
09/11/2003 | US20030171349 Novel muscarinic receptor agonists |
09/11/2003 | US20030171213 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an |
09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
09/11/2003 | US20030168970 Luminescent element material and luminescent element comprising the same |
09/10/2003 | EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
09/10/2003 | EP1341776A1 Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides |
09/10/2003 | EP1341774A1 Fused heteroaromatic glucokinase activators |
09/10/2003 | EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
09/10/2003 | EP1341534A2 Compounds having fungicidal activity and processes to make and use same |
09/10/2003 | EP1135388B1 3-(heterocyclyl)-substituted benzoylpyrazols |
09/10/2003 | EP0873341B1 Epothilone derivatives, preparation and use |
09/10/2003 | EP0851862B1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders |
09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
09/10/2003 | CN1440966A Naphthaquinone thiazole as organic as third-order non-linear optical material and its chemical synthesis process |
09/09/2003 | US6617460 Process for preparing toluenesulfinates |
09/09/2003 | US6617341 Insecticidal 2-iminothiazole derivatives |
09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
09/04/2003 | WO2003072577A1 Thiazole derivatives as npy receptor antagonists |
09/04/2003 | WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
09/04/2003 | WO2003072556A1 Glutaminyl based dpiv inhibitors |
09/04/2003 | WO2003072554A1 Azole compounds |
09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
09/04/2003 | WO2003072532A1 Ester compound and medicinal use thereof |
09/04/2003 | WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
09/04/2003 | WO2003072102A1 Peroxisome proliferator activated receptor modulators |
09/04/2003 | WO2003072101A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases |
09/04/2003 | WO2003072100A1 Peroxisome proliferator activated receptor modulators |
09/04/2003 | WO2003053367A3 Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
09/04/2003 | WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |